Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120000) titled 'Effect of a Single Dose of Henagliflozin on Fractional Excretion of Sodium in Patients with Cirrhosis and Refractory Hepatic Hydrothorax and/or Ascites: A Multicenter, Open-Label, Randomized Controlled Trial' on March 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Liver cirrhosis
Intervention:
Study Group:Henagliflozin 10 mg orally once daily
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-06
Target Sample Size: Study Group:15;Control Group:15;
Countries of Recruitment:
Chin...